Kabra Drugs Ltd — Insider Trading, 26-09-2025: Insider Trading / SAST

Kabra Drugs Limited has announced the closure of its trading window for Designated Persons and their immediate relatives, effective from October 1st. This window will remain closed until 48 hours after the declaration of the financial results for the quarter ended September 30th. The specific date for the board meeting to consider these financial results will be announced separately. This action aligns with standard insider trading compliance, aiming to maintain market integrity ahead of key financial disclosures for shareholders.